A Study of CDX-0159 in Patients With Chronic Inducible Urticaria

NCT05405660 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

196

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Inducible Urticaria

Interventions

BIOLOGICAL: barzolvolimab
DRUG: Matching Placebo

Sponsor

Celldex Therapeutics